The Therapeutic Effect and Potential Application of Psilocybin

Authors

  • Tianran Liu

DOI:

https://doi.org/10.54097/3cfwjn09

Keywords:

Psilocybin; Mental illness; Treatment.

Abstract

Mental illness is a hot topic of concern worldwide. The psilocybin has great potential in the treatment of mental disorders, but there is still a research gap on whether it can truly be applied in the treatment of mental disorders. Therefore, this research explores the feasibility of psilocybin’s true application in the treatment of mental disorders by collecting relevant literature on its experiments in recent years, analyzing the data and experimental results in detail. Research has found that in the treatment of mental disorders, psilocybin does have significant effects compared to traditional drugs. Psilocybin’s role is more pronounced in cancer patients with more severe and complex mental disorders, greatly reducing their depression index and effectively controlling the condition of substance abuse patients. And through popular science, some healthcare professionals who care for patients with eating disorders hope to apply psilocybin for treatment. Psilocybin also does have certain unresolved side effects. Overall, from a scientific perspective, psilocybin can indeed effectively treat mental illnesses, and morally speaking, healthcare professionals are willing to introduce psilocybin into the treatment of patients with mental illnesses. One day, when psilocybin is widely used to treat mental illnesses, it will be a significant progress in medical history.

Downloads

Download data is not yet available.

References

Metzner R. Reflections on the concord prison project and the follow-up study. Journal of psychoactive drugs, 1998, 30(4): 427-428.

Beck A T, Ward C H, Mendelson M, et al. An inventory for measuring depression. Archives of general psychiatry, 1961, 4(6): 561-571.

Spielberger CD, Gorsuch RL, Lushene R, Vagg PR, Jacobs GA. State Trait Anxiety Inventory. Menlo Park, CA: Mind Garden; 1970. https://jamanetwork.com/journals/jamapsychiatry/fullarticle.

Carhart-Harris R L, Roseman L, Bolstridge M, et al. Psilocybin for treatment -resistant depression: fMRI -measured brain mechanisms. Sci Rep, 2017, 7(1): 13187.

Roseman L, Demetriou L, Wall M B, et al. Increased amygdala responses to emotional faces after psilocybin for treatment - resistant depression. Neuropharmacology, 2018,142: 263-269.

Davis A K, Barrett F S, May D G, et al. Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial. JAMA Psychiatry, 2021, 78(5): 481-489.

Ross S, Bossis A, Guss J, et al. Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life -threatening cancer: a randomized controlled trial. J Psychopharmacol, 2016, 30(12): 1165-1180.

Downey A E, Boyd M, Chaphekar A V, et al. “But the reality is it's happening”: A qualitative study of eating disorder providers about psilocybin‐assisted psychotherapy. International Journal of Eating Disorders, 2023: 1-7.

Goodwin G M, Aaronson S T, Alvarez O, et al. Single-dose psilocybin for a treatment-resistant episode of major depression. New England Journal of Medicine, 2022, 387(18): 1637-1648.

Carhart-Harris R L, Bolstridge M, Rucker J, et al. Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. The Lancet Psychiatry, 2016, 3(7): 619-627.

Downloads

Published

29-12-2023

How to Cite

Liu, T. (2023). The Therapeutic Effect and Potential Application of Psilocybin. Highlights in Science, Engineering and Technology, 74, 572-576. https://doi.org/10.54097/3cfwjn09